Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28
Published July 19, 2023 · Recall initiated: July 5, 2023
Summary
FDA records drug Class II recall D-0913-2023, published July 19, 2023 and initiated July 5, 2023. Recalling firm: Teva Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 180 bottles; Lot: Lot # 100037220, Exp 10/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Moisture Limits: Water (moisture) content above the approved product specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email if SUNITINIB MALATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SUNITINIB MALATE
- Manufacturer
- Teva Pharmaceuticals USA Inc
- Distributor
- Product was distributed to 3 wholesalers/distributors who further distributed the product Nationwide in the USA.
- Lot
- Lot # 100037220, Exp 10/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478.December 11, 2024
- FDASunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDCDecember 11, 2024
- FDAAllergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDCJuly 19, 2023
- FDATiagabine Hydrochloride Tablets, 2 mg, 30-count bottle, Distributed by Sun Pharmaceutical Industries. Inc.July 19, 2023
- FDAPicnic, Fexofenadine Hydrochloride Tablets, 180 mg, Antihistamine, 90-count cartons, Distributed by: ThirtyJuly 19, 2023
- FDABig Machine Distillery Hand Sanitizer Non-Sterile Solution Alcohol Antiseptic 80% Topical Solution, ProducedJuly 19, 2023
Questions about this recall
Was Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28 recalled?
Yes. FDA published recall D-0913-2023 on July 19, 2023. Reported hazard: Failed Moisture Limits: Water (moisture) content above the approved product specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SUNITINIB MALATE.